RXi Pharmaceuticals Corp., a clinical-stage biotechnology company based in Marlborough, has been granted a Chinese patent for the composition and methods of use for compounds that may be used to treat dermal scarring, the company announced Monday.
A three-year contract has been ratified by 198 nurses at the Marlborough Hospital, representing the last Massachusetts Nurses Association-represented hospital to settle a contract, the association announced Wednesday.
Nuclea Biotechnologies, Inc., based in Pittsfield but with operations in Worcester, has announced that a kit using Carbonic Anhydrase IX has been classified by the Food and Drug Administration (FDA) as a Class I in vitro diagnostic (IVD) device for use on a Ventana Benchmark XT instrument.
Health care workers on Tuesday spoke out in favor of a proposed bill, which proponents say will reduce health care spending while boosting community hospitals, during a legislative hearing before the Joint Committee on Health Care Financing.
Maintaining work-life balance is challenging for any parent, but for those who have children with autism, the problem is compounded.
Speakers featured at the second annual Central Massachusetts Autism Summit held at Assumption College Tuesday morning provided insight into the myriad obstacles parents face. Often, children with autism have other health conditions that add to their needs, from psychiatric diagnoses to allergies and gastrointestinal disorders, according to a presentation by Dr. Jean Frazier, director of the Eunice Kennedy Shriver Center at UMass Medical School in Worcester.
Four Central Massachusetts community health centers are among 1,184 health centers nationwide selected to receive federal money to expand access to health care services in the communities they serve.